Patient participation in high-risk research could benefit novel drug trials Published on September 19, 2013 at 2:47 AM · Individuals have a right to participate in risky research trials, which might harm their health or even kill them, and institutional… Read More ›
Institutional Review Board
Documentary Evidence Reveals Motives of Pharmaceutical “Seeding” Trials
Re-Post for filing 2008 Clinical studies that are designed by pharmaceutical companies to promote use of their drugs are called “seeding” trials. While much has been written about the marketing tactics of the pharmaceutical industry, seeding trials have not been… Read More ›
Single dose of hallucinogen may create lasting personality change – psilocybin
Johns Hopkins study of ingredient in ‘magic mushrooms’ found participants exhibited more ‘openness’ A single high dose of the hallucinogen psilocybin, the active ingredient in so-called “magic mushrooms,” was enough to bring about a measureable personality change lasting at least… Read More ›
Engineering Evil 